Cocoa and dark chocolate is a rich source of flavonoids and flavonoid-related compounds with strong antioxidant effects. Studies suggest that cocoa flavanoids improve the health of blood vessels and reduce the oxidation of LDL cholesterol that can lead to clogged arteries.
|
|
Omega 3 fatty acids have been proven to play a part in keeping cholesterol levels low, stabilizing irregular heart beat and reducing blood pressure which helps to lower the risk of heart attacks and other heart diseases.
Since Cocoa Tickles contains essential fatty acids EPA and DHA, which prevent the formation of lipoproteins that obstruct the arteries, it improves the blood flow in the arteries and promotes good cardiovascular health. It in turn lowers bad cholesterol and increases the “good” kind. Can you imagine a better way to tickle your heart into a healthy bliss? |
|
AHA Recommendation 
Omega-3 fatty acids benefit the heart of healthy people, and those at high risk of — or who have — cardiovascular disease.
We recommend eating fish (particularly fatty fish) at least twice a week. Fish is a good source of protein and doesn't have the high saturated fat that fatty meat products do. Fatty fish like mackerel, lake trout, herring, sardines, albacore tuna and salmon are high in two kinds of omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
The table below is a good guide for consumption of omega-3 fatty acids.
Summary of Recommendations for Omega-3 Fatty Acid Intake.
|
Population |
Recommendation |
|
Patients without documented coronary
heart disease (CHD) |
Eat a variety of (preferably fatty)
fish at least twice a week. Include oils and foods
rich in alpha-linolenic acid (flaxseed, canola and
soybean oils; flaxseed and walnuts). |
|
Patients with documented CHD |
Consume about 1 g of EPA+DHA per day,
preferably from fatty fish. EPA+DHA supplements
could be considered in consultation with the
physician. |
|
Patients who need to lower
triglycerides |
2 to 4 grams of EPA+DHA per day
provided as capsules under a physician’s care. |
|
Patients taking more than 3 grams of omega-3 fatty acids from
supplements should do so only under a physician’s care. High
intakes could cause excessive bleeding in some people.
Background
In 1996 the American Heart Association released its Science
Advisory, “Fish Consumption, Fish Oil, Lipids and Coronary
Heart Disease.” Since then important new findings have been
reported about the benefits of omega-3 fatty acids on
cardiovascular disease. These include evidence from
randomized, controlled clinical trials. New information has
emerged about how omega-3 fatty acids affect heart function
(including antiarrhythmic effects), hemodynamics (cardiac
mechanics) and arterial endothelial function. These findings
are outlined in our November 2002 Scientific Statement, “Fish
Consumption, Fish Oil, Omega-3 Fatty Acids and Cardiovascular
Disease.”
The ways that omega-3 fatty acids reduce CVD risk are still
being studied. However, research has shown that they
• decrease risk of arrhythmias, which can lead to sudden
cardiac death
• decrease triglyceride levels
• decrease growth rate of atherosclerotic plaque
• lower blood pressure (slightly)
What do epidemiological and observational studies show?
Epidemiologic and clinical trials have shown that omega-3
fatty acids reduce CVD incidence. Large-scale epidemiologic
studies suggest that people at risk for coronary heart disease
benefit from consuming omega-3 fatty acids from plants and
marine sources.
The ideal amount to take isn’t clear. Evidence from
prospective secondary prevention studies suggests that taking
EPA+DHA ranging from 0.5 to 1.8 grams per day (either as fatty
fish or supplements) significantly reduces deaths from heart
disease and all causes. For alpha-linolenic acid, a total
intake of 1.5–3 grams per day seems beneficial.
Randomized clinical trials have shown that omega-3 fatty
acid supplements can reduce cardiovascular events (death,
non-fatal heart attacks, non-fatal strokes). They can also
slow the progression of atherosclerosis in coronary patients.
However, more studies are needed to confirm and further define
the health benefits of omega-3 fatty acid supplements for
preventing a first or subsequent cardiovascular event. For
example, placebo-controlled, double-blind, randomized clinical
trials are needed to document the safety and efficacy of
omega-3 fatty acid supplements in high-risk patients (those
with type 2 diabetes, dyslipidemia, hypertension and smokers)
and coronary patients on drug therapy. Mechanistic studies on
their apparent effects on sudden death also are needed.
Increasing omega-3 fatty acid intake through foods is
preferable. However, coronary artery disease patients may not
be able to get enough omega-3 by diet alone. These people may
want to talk to their doctor about taking a supplement.
Supplements also could help people with high triglycerides,
who need even larger doses. The availability of high-quality
omega-3 fatty acid supplements, free of contaminants, is an
important prerequisite to their use.
Related AHA publications:
• An Eating Plan for Healthy Americans
• Easy Food Tips for Heart-Healthy Eating (also in Spanish)
Related AHA Scientific Statements Diet/Nutrition
|